Alpha 2.0
Login Register
» Articles » PMID: 5296393

A Controlled Field Trial and Laboratory Study of Five Typhoid Vaccines in the USSR

Overview
Journal Bull World Health Organ
Specialty Public Health
Date 1966 Jan 1
PMID 5296393
Citations 20
Authors
L B HEJFEC
L V SALMIN
M Z Lejtman
M L KUZMINOVA
A V Vasileva
L A LEVINA
T G Bencianova
E A Pavlova
A A Antonova
Affiliations
Soon will be listed here.
Abstract

A controlled field trial of typhoid vaccines was carried out in the USSR in 1962. It was the fifth and last of a series. Five preparations were tested, the most effective being a heat-killed divalent vaccine prepared from aerated broth culture. The results of a laboratory study of the vaccines were not in complete agreement with the data from the field trial. No correlation was found between the effectiveness of vaccines and the data from laboratory tests as to their potency, and the authors suggest that differences in effectiveness may be due to varying degrees of damage to biological components during the different production processes. The effectiveness is also sensitive to dosage.

Citing Articles

Global Typhoid Fever Incidence: A Systematic Review and Meta-analysis.

Marchello C, Hong C, Crump J Clin Infect Dis. 2019; 68(Suppl 2):S105-S116.

PMID: 30845336 PMC: 6405273. DOI: 10.1093/cid/ciy1094.

Vaccines for preventing typhoid fever.

Milligan R, Paul M, Richardson M, Neuberger A Cochrane Database Syst Rev. 2018; 5:CD001261.

PMID: 29851031 PMC: 6494485. DOI: 10.1002/14651858.CD001261.pub4.

Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Simon R, Levine M Hum Vaccin Immunother. 2012; 8(4):494-8.

PMID: 22370510 PMC: 3426074. DOI: 10.4161/hv.19158.

Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.

Peacock S, Limmathurotsakul D, Lubell Y, Koh G, White L, Day N PLoS Negl Trop Dis. 2012; 6(1):e1488.

PMID: 22303489 PMC: 3269417. DOI: 10.1371/journal.pntd.0001488.

Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005.

Crump J, Ram P, Gupta S, Miller M, Mintz E Epidemiol Infect. 2007; 136(4):436-48.

PMID: 17686194 PMC: 2870843. DOI: 10.1017/S0950268807009338.

References
1.
Spaun J . Determination of Salmonella typhi O and Vi antibodies by haemagglutination. Acta Pathol Microbiol Scand. 1952; 31(4):462-9. DOI: 10.1111/j.1699-0463.1952.tb00214.x. View
2.
Landy M, Lamb E . Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen. Proc Soc Exp Biol Med. 1953; 82(4):593-8. DOI: 10.3181/00379727-82-20188. View
3.
Landy M, TRAPANI R, Clark W . Studies on the O antigen of Salmonella typhosa. III. Activity of the isolated antigen in the hemagglutination procedure. Am J Hyg. 1955; 62(1):54-65. DOI: 10.1093/oxfordjournals.aje.a119766. View
4.
Spaun J . Biological standardization of typhoid vaccines by antibody measurements. Acta Pathol Microbiol Scand. 1956; 39(6):469-80. DOI: 10.1111/j.1699-0463.1956.tb05074.x. View
5.
BENENSON A . SEROLOGICAL RESPONSES OF MAN TO TYPHOID VACCINES. Bull World Health Organ. 1964; 30:653-62. PMC: 2554993. View